Pituitary pars intermedia dysfunction: equine Cushing's disease

Veterinary Clinics of North America - Equine Practice

Volumn 18, Issue 2, 2002, Pages 237-270

  Schott II, Harold C ^a  

^a Center for Comparative Medicine and Translational Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

CORTICOTROPIN; DEXAMETHASONE; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; PERGOLIDE;

ANIMAL; ANIMAL DISEASE; BLOOD; CUSHING DISEASE; FEMALE; HISTOLOGY; HORSE; HORSE DISEASE; HYPOPHYSIS; MALE; METABOLISM; PATHOLOGY; REVIEW; SECRETION; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; DEXAMETHASONE; DOPAMINE AGONISTS; FEMALE; HORSE DISEASES; HORSES; HYDROCORTISONE; MALE; PERGOLIDE; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; TREATMENT OUTCOME;

EID: 2542618812     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0739(02)00018-4     Document Type: Review

References (105)

1. Berne R.M., and Levy M.N. The hypothalamus and pituitary gland. Physiology. 4th edition (1998), Mosby, St. Louis 872-909
2. Malven PV. Pituitary gland neuroendocrinology. In: Proceedings of the 15th Annual Forum of the American College of Veterinary Internal Medicine. 1997. p. 462-467.
3. van der Kolk J.H. Diseases of the pituitary gland, including hyperadrenocorticism. In: Watson T.D. (Ed). Metabolic and endocrine problems of the horse (1998), WB Saunders, London 41-59
4. Cotran R.S., Kumar V., and Collins T. The endocrine system. Robbins pathologic basis of disease. 6th edition (1999), WB Saunders, Philadelphia 1121-1169
5. Heinrichs M., Baumgärtner W., and Capen C.C. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses. Vet Pathol 27 (1990) 419-425
6. Okada T., Shimomuro T., Oikawa M., et al. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in Thoroughbreds. Am J Vet Res 58 (1997) 920-924
7. Tan J.H., and Sasaki F. Effect of age on immunocytochemical staining characteristics of adenohypophyseal cells in Mongolian pony mares and stallions. Am J Vet Res 61 (2000) 826-831
8. Amann J.F., Smith R.M., Ganjam V.K., et al. Distribution and implications of β-endorphin and ACTH-immunoreactive cells in the intermediate lobe of the hypophysis in healthy equids. Am J Vet Res 48 (1987) 323-327
9. Alexander S.L., Irvine C.H.G., and Donald R.A. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses. Front Neuroendocrinol 17 (1996) 1-50
10. Alexander S.L., Roud H.K., and Irvine C.H.G. Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotropin in horses. J Endocrinol 153 (1997) 401-409
11. Alexander S.L., and Irvine C.H.G. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses. Endocrinology 136 (1995) 5139-5147
12. Yamaguchi H., Aiba A., Nakamura K., et al. Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells 1 (1996) 253-268
13. Beatty D.M., Morris S.J., and Chronwall B.M. Heterogeneity in POMC expression among explanted melanotropes decreases with time in culture and bromocriptine treatment. Peptides 19 (1998) 659-665
14. Wilson M.G., Nicholson W.E., Holscher M.A., et al. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. Endocrinology 110 (1982) 941-954
15. Millington W.R., Dybdal N.O., Dawson R., et al. Equine Cushing's disease: differential regulation of β-endorphin processing in tumors of the intermediate pituitary. Endocrinology 123 (1988) 1598-1604
16. James V.H.T., Horner M.W., Moss M.S., et al. Adrenocortical function in the horse. J Endocrinol 48 (1970) 319-335
17. Larsson M., Edqvist L.E., Ekman L., et al. Plasma cortisol in the horse, diurnal rhythm and effects of exogenous ACTH. Acta Vet Scand 20 (1979) 16-24
18. Toutain P.L., Oukessou M., Autefage A., et al. Diurnal and episodic variations of plasma hydrocortisone concentrations in horses. Domest Anim Endocrinol 5 (1988) 55-59
19. Hoffsis G.F., and Murdick P.W. The plasma concentrations of corticosteroids in normal and diseased horses. JAVMA 157 (1970) 1590-1594
20. Irvine C.H.G., and Alexander S.L. Factors affecting the circadian rhythm in plasma cortisol concentration in horses. Domest Anim Endocrinol 11 (1994) 317-337
21. Messer N.T., Johnson P.J., Refsal K.R., et al. Effect of food deprivation on baseline iodothyronine and cortisol concentrations in healthy, adult horses. Am J Vet Res 56 (1995) 116-121
22. Gayrard V., Alvinirie M., and Toutain P.L. Interspecies variations of corticosteroid-binding globulin parameters. Endocrinology 13 (1996) 35-45
23. Alexander S.L., and Irvine C.H.G. The effect of social stress on adrenal axis activity in horses: the importance of monitoring corticosteroid-binding globulin capacity. J Endocrinol 157 (1998) 425-432
24. Boujon C.E., Bestetti G.E., Meier H.P., et al. Equine pituitary adenoma: a functional and morphological study. J Comp Pathol 109 (1993) 163-178
25. van der Kolk J.H., Ijzer J., Overgaauw P.A.M., et al. Pituitary-independent Cushing's syndrome in a horse. Equine Vet J 33 (2001) 110-112
26. van der Kolk JH. Relation between relative pituitary weight in horses with Cushings disease and some plasma and clinical parameters [abstract]. In: Proceedings of the 35th Congress of the British Equine Veterinary Association. 1996. p. 82-83.
27. Horvath C.J., Ames T.R., Metz A.L., et al. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse. JAVMA 192 (1988) 367-371
28. van der Kolk J.H., Kalsbeek H.C., van Garderen E., et al. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992). Vet Rec 133 (1993) 594-597
29. Wallace M.A., Crisman M.V., Pickett J.P., et al. Central blindness associated with pituitary adenoma in a horse. Equine Pract 18 (1996) 8-13
30. Orth D.N., and Nicholson W.E. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease. Endocrinology 111 (1982) 559-563
31. Orth D.N., Holscher M.A., Wilson M.G., et al. Equine Cushing's disease: plasma immunoreactive proopiomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology 110 (1982) 1430-1441
32. Dybdal N.O., Hargreaves K.M., Madigan J.E., et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. JAVMA 204 (1994) 627-632
33. Ooki T., Kotsu T., Kinutani M., et al. Pars intermedia of the hypophysis of rats after early-postnatal lesions of the basal hypothalamus. Quantitative and qualitative observations. Neuroendocrinology 11 (1973) 22-45
34. Levy M, Dybdal N. Pituitary pars intermedia dysfunction in the horse. Part I: clinical signs and pathophysiology. In: Proceedings of the 15th Annual Forum of the American College of Veterinary Internal Medicine. 1997. p. 468-469.
35. Evans DR. The recognition and diagnosis of a pituitary tumor in the horse. In: Proceedings of the 18th Annual Convention of the American Association of Equine Practitioners. 1972. 417-9.
36. Hillyer M.H., Taylor F.R.G., Mair T.S., et al. Diagnosis of hyperadrenocorticism in the horse. Equine Vet Educ 4 (1992) 131-134
37. Love S. Equine Cushing's disease. Br Vet J 149 (1993) 139-153
38. Schott HC, Coursen CL, Eberhart SW, et al. The Michigan Cushing's project. Proceedings of the 47th Annual Convention of the American Association of Equine Practitioners. 2001. 22-4.
39. van der Kolk J.H. Equine Cushing's disease. Equine Vet Educ 9 (1997) 209-214
40. Gribble D.H. The endocrine system. In: Catcott E.J., and Smithcors J.F. (Eds). Equine medicine and surgery. 2nd edition (1972), American Veterinary Publications, Wheaton (IL) 433-457
41. Auer D.E., Wilson R.G., Groenendijk S., et al. Glucose metabolism in a pony mare with a tumour of the pituitary gland pars intermedia. Aust Vet J 64 (1987) 379-382
42. Beck D.J. Effective long-term treatment of a suspected pituitary adenoma with bromocriptine mesylate in a pony. Equine Vet Educ 4 (1992) 119-122
43. Eriksson K., Dyrendahl S., and Grimfelt D. A case of hirsutism in connection with hypophyseal tumour in a horse. Nord Vet Med 8 (1956) 807-814
44. Field J.R., and Wolf C. Cushing's syndrome in a horse. Equine Vet J 20 (1988) 301-304
45. King J.M., Kavanaugh J.F., and Bentinck-Smith J. Diabetes mellitus with pituitary neoplasms in a horse and a dog. Cornell Vet 52 (1962) 133-145
46. Loeb W.F., Capen C.C., and Johnson L.E. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses. Cornell Vet 56 (1966) 623-639
47. Moore J.N., Steiss J., Nicholson W.E., et al. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse. Endocrinology 104 (1979) 576-582
48. Okada T., Yuguchi K., Kiso Y., et al. A case of a pony with Cushing's disease. J Vet Med Sci 59 (1997) 707-710
49. Corke M.J. The pathogenesis of cutaneous signs in endocrine disease. Equine Vet Educ 4 (1992) 127-130
50. Holscher M.A., Linnabary R.L., Netsky M.G., et al. Adenoma of the pars intermedia and hirsutism in a pony. Vet Med Small Anim Clin 73 (1978) 1197-1200
51. Green E.M., and Hunt E.L. Hypophyseal neoplasia in a pony. Compend Contin Educ Pract Vet 7 (1985) S249-S257
52. Baker J.R., and Ritchie H.E. Diabetes mellitus in the horse: a case report and review of the literature. Equine Vet J 6 (1974) 7-11
53. Pass M.A., Pollitt S., and Pollitt C.C. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J Suppl 26 (1998) 133-138
54. French K., Pollitt C.C., and Pass M.A. Pharmacokinetics and metabolic effects of triamcinolone acetate and their possible relationships to glucocorticoid-induced laminitis in horses. J Vet Pharmacol Ther 23 (2000) 287-292
55. Couëtil L., Paradis M.R., and Knoll J. Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J Vet Intern Med 10 (1996) 1-6
56. Schott H.C. Polyuria and polydipsia. In: Reed S.M., and Bayly W.M. (Eds). Equine internal medicine (1998), WB Saunders, Philadelphia 895-901
57. Allen J.R., Barbee D.D., and Crisman M.V. Diagnosis of equine pituitary tumors by computed tomography-part 1. Compend Contin Educ Pract Vet 10 (1988) 1103-1106
58. Couëtil L.L. New developments in equine Cushing's disease. Equine Pract 18 (1996) 28-32
59. Tomlinson J.W., Bujalska I., Stewart P.M., et al. The role of 11β-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocr Res 26 (2000) 711-722
60. Sweeney C.R., Stebbins K.E., Schelling C.G., et al. Hypertrophic osteopathy in a pony with a pituitary adenoma. JAVMA 195 (1989) 103-105
61. Beech J. Tumors of the pituitary gland (pars intermedia). In: Robinson N.E. (Ed). Current therapy in equine medicine (1983), WB Saunders, Philadelphia 164-169
62. Dybdal N.O. Pituitary pars intermedia dysfunction (equine Cushing's-like disease). In: Robinson N.E. (Ed). Current therapy in equine medicine 4 (1997), WB Saunders, Philadelphia 499-501
63. McFarlane D., Sellon D.C., Gaffney D., et al. Hematologic and serum biochemical variables and plasma corticotropin concentration in healthy aged horses. Am J Vet Res 59 (1998) 1247-1251
64. Ralston S.L., Nockels C.F., and Squires E.L. Differences in diagnostic test results and hematologic data between aged and young horses. Am J Vet Res 49 (1988) 1387-1392
65. Cohen N.D., and Carter G.K. Steroid hepatopathy in a horse with glucocorticoid-induced hyperadrenocorticism. JAVMA 200 (1992) 1682-1684
66. Johnson S.E., and Scherding R.G. Diseases of the liver and biliary tract. In: Birchard S.J., and Scherding R.G. (Eds). Saunders manual of small animal practice. 2nd edition (2000), WB Saunders, Philadelphia 824-873
67. Naylor J.M., Kronfeld D.S., and Acland H. Hyperlipemia in horses, effects of undernutrition and disease. Am J Vet Res 41 (1980) 899-905
68. Moore B.R., Abood S.K., and Hinchcliff K.W. Hyperlipemia in 9 miniature horses and miniature donkeys. J Vet Intern Med 8 (1994) 376-381
69. Eiler H., Oliver J.W., Andrews F.M., et al. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma. JAVMA 211 (1997) 79-81
70. Douglas R. Circadian cortisol rhythmicity and equine Cushing's-like disease. J Equine Vet Sci 19 (1999) 684-753
71. Eiler H., Oliver J., and Goble D. Combined dexamethasone-suppression cosyntropin (synthetic ACTH-) stimulation test in the horse: a new approach to testing of adrenal gland function. Am J Vet Res 41 (1980) 430-434
72. Sojka J.E., Johnson M.A., and Botoms G.D. The effect of starting time on dexamethasone suppression test results in horses. Domest Anim Endocrinol 10 (1993) 1-5
73. Korbonits M., Bujalska I., Shimojo M., et al. Expression of 11β-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. J Clin Endocrinol Metab 86 (2001) 2728-2733
74. Kreiger D.T., and Luria M. Plasma ACTH and cortisol responses to TRF, vasopressin, or hypoglycemia in Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab 44 (1977) 361-368
75. Pieters G.F.M., Smals A.G.H., Benraad T.J., et al. Plasma cortisol response to TRF and LHRF in Cushing's disease. J Clin Endocrinol Metab 48 (1979) 874-876
76. Beech J., and Garcia M. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma. Am J Vet Res 46 (1985) 1941-1943
77. van der Kolk J.H., Wensing T., Kalsbeek H.C., et al. Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest Anim Endocrinol 12 (1995) 35-39
78. Singh A.K., Jiang Y., White T., et al. Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol in blood samples obtained from dogs, cats, and horses. J Vet Diagn Invest 9 (1997) 261-268
79. Reeves H.J., Lees R., and McGowan C.M. Measurement of basal serum insulin concentration in the diagnosis of Cushing's disease in ponies. Vet Rec 149 (2001) 449-452
80. Beloff-Chain A., Morton J., Dunmore S., et al. Evidence that the insulin secretagogue, beta-cell-tropin, is ACTH22-39. Nature 301 (1983) 255-258
81. Johnson P.J., and Ganjam V.K. Laminitis, "hypothyroidism," and obesity: a peripheral Cushingoid syndrome in horses?. Proceedings of the 17th Annual Forum of the American College of Veterinary Internal Medicine (1999) 192-194
82. Garcia M.C., and Beech J. Equine intravenous glucose tolerance tests: glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenomas. Am J Vet Res 47 (1986) 570-572
83. van der Kolk J.H., Kalsbeek H.C., Wensing T., et al. Urinary concentration of corticoids in normal horses and horse with hyperadrenocorticism. Res Vet Sci 56 (1994) 126-128
84. van der Kolk J.H., Nachreiner R.F., Schott H.C., et al. Salivary and plasma concentration of cortisol in normal horses and horses with Cushing's disease. Equine Vet J 33 (2001) 211-213
85. Levy M, Blevins WE, Janovitz EB. Radiological diagnosis of pituitary adenoma in the horse. In: Proceedings of the Third Congress of the World Equine Veterinary Association. 1993. p. 18.
86. Beech J. Treatment of hypophysial adenomas. Compend Contin Educ Pract Vet 16 (1994) 921-923
87. Dybdal NO, Levy M. Pituitary pars intermedia dysfunction in the horse. Part II: diagnosis and treatment. In: Proceedings of the 15th Annual Forum of the American College of Veterinary Internal Medicine. 1997. p. 470-2.
88. Orrego J.J., and Barkan A.L. Pituitary disorders. Drug treatment options. Drugs 59 (2000) 93-106
89. Meij B.P., Voorhout G., van Den Ingh T., et al. Transphenoidal hypophysectomy in beagle dogs: evaluation of a microsurgical technique. Vet Surg 26 (1997) 295-309
90. McGowan C.M., and Neiger R. Efficacy of trilostane in the management of equine Cushing's disease. [abstract 202]. J Vet Intern Med 15 (2001) 322
91. Munoz M.C., Doreste F., Ferrer O., et al. Pergolide treatment for Cushing's syndrome in a horse. Vet Rec 139 (1996) 41-43
92. Perkins G., Lamb S., Erb H.N., et al. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. [abstract 58]. J Vet Intern Med 15 (2001) 286
93. Fischer J.L., and Moriarty M.C. Control of bioactive corticotropin release from the neuro-intermediate lobe of the rat pituitary in vitro. Endocrinology 100 (1977) 1047-1054
94. Williams PD. Equine Cushing's syndrome-retrospective study of twenty four cases and response to medication [abstract]. In: Proceedings of the 34th Congress of the British Equine Veterinary Association. 1995. p. 41.
95. Peters DF, Erfle JB, Slobojan GT. Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's syndrome). In: Proceedings of the 41st Annual Convention of the American Association of Equine Practitioners. 1995. p. 154-5.
96. Deem D.A., and Whitlock R.H. The pituitary gland. In: Mansmann R.A., McAllister E.S., and Pratt P.W. (Eds). Equine medicine and surgery. 3rd edition vol 2 (1982), American Veterinary Publications, Santa Barbara 885-891
97. Schutzer W.E., Kerby J.L., and Holtan D.W. Differential effect of trilostane on the progestin milieu in the pregnant mare. J Reprod Fertil 107 (1996) 241-248
98. Engelhardt D., and Weber M.M. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 49 (1994) 261-267
99. Elliott M. Cushing's disease: a new approach to therapy in equine and canine patients. Br Homeopath J 90 (2001) 33-36
100. Harman J., and Ward M. The role of nutritional therapy in the treatment of equine Cushing's syndrome and laminitis. Altern Med Rev 6 Suppl (2001) S4-S16
101. McCarty M.F. Toward practical prevention of type 2 diabetes. Med Hypotheses 54 (2000) 786-793
102. Anonymous. Cresty and laminitic?. Give'em magnesium. Horse Journal 8 1 (2001) 3-5
103. Ott E.A., and Kivipelto J. Influence of chromium tripicolinate on growth and glucose metabolism in yearling horses. J Anim Sci 77 (1999) 3022-3030
104. Anonymous. Herbal offers hope for Cushing's syndrome. Available at:. http//www.equinehealthandherbal.co.uk Accessed June, 2002
105. Barausse M., Attanasio R., Dallabonzana D., et al. From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease. J Endocrinol Invest 23 (2000) 107-111